EQT
45
6
ROK
46
2
HSIC
47
5
CPB
40
-2
ZTS
49
2
MU
46
6
UNP
55
2
WEC
51
6
CME
48
2
MCD
65
2
STI
19
12
AN
49
3
UAL
77
4
AEP
51
6
AVY
53
-8
SE
61
4
BAX
44
-3
UNH
53
4
PDCO
46
3
EMN
56
-4
EQT
45
6
ROK
46
2
HSIC
47
5
CPB
40
-2
ZTS
49
2
MU
46
6
UNP
55
2
WEC
51
6
CME
48
2
MCD
65
2
STI
19
12
AN
49
3
UAL
77
4
AEP
51
6
AVY
53
-8
SE
61
4
BAX
44
-3
UNH
53
4
PDCO
46
3
EMN
56
-4
Financhill
Back

ProShares UltraShort MSCI Brazil Capped Vs. Kymera Therapeutics Industry Stock Comparison

Sell
50

BZQ
ProShares UltraShort MSCI Brazil Capped

Last Price:
13.60
Seasonality Move:
-6.06%
Buy
71

KYMR
Kymera Therapeutics

Last Price:
47.27
Seasonality Move:
65.72%
Sell
50
ProShares UltraShort MSCI Brazil Capped (BZQ) is a Sell

Is ProShares UltraShort MSCI Brazil Capped a Buy, Sell or Hold?

  • The current ProShares UltraShort MSCI Brazil Capped [BZQ] share price is $13.55. The Score for BZQ is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • BZQ is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
71
Kymera Therapeutics (KYMR) is a Buy

Is Kymera Therapeutics a Buy, Sell or Hold?

  • The current Kymera Therapeutics [KYMR] share price is $49.02. The Score for KYMR is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

BZQ Stock Price Chart

What is ProShares UltraShort MSCI Brazil Capped's stock price today?

  • The ProShares UltraShort MSCI Brazil Capped share price today is $13.55
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BZQ is experiencing slight selling pressure.

KYMR Stock Price Chart

What is Kymera Therapeutics's stock price today?

  • The Kymera Therapeutics share price today is $49.02
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.

BZQ Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.2 Buy
Relative Strength Index (14 RSI): 57.78 Buy
Chaikin Money Flow: -352 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (12.45 - 13.33) Buy
Bollinger Bands (100): (12.52 - 14.56) Buy

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.28 Sell
Relative Strength Index (14 RSI): 59.12 Buy
Chaikin Money Flow: 317205 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.81 - 49.49) Buy
Bollinger Bands (100): (34.86 - 47.92) Buy

BZQ Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 13.38 Buy
20-day SMA: 12.97 Buy
50-day SMA: 12.75 Buy
200-day SMA: 12.54 Buy
8-day EMA: 13.35 Buy
20-day EMA: 13.09 Buy
50-day EMA: 13.04 Buy
200-day EMA: 13.16 Buy

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.58 Buy
20-day SMA: 46.67 Buy
50-day SMA: 46.11 Buy
200-day SMA: 38.62 Buy
8-day EMA: 45.67 Buy
20-day EMA: 45.85 Buy
50-day EMA: 45.2 Buy
200-day EMA: 38.5 Buy

ProShares UltraShort MSCI Brazil Capped Earnings Growth & BZQ Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Kymera Therapeutics Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and a decrease next year of $0.47 per share.

ProShares UltraShort MSCI Brazil Capped Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):